Schedule 13G ownership disclosure
Celsus Therapeutics Plc.
Security class unavailable · CUSIP: 15119A103
Event date: 2015-02-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-015126
- Form type
- SC 13G
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Mar 10, 2015
- Reporting period
- Feb 17, 2015
- Description
- Schedule 13G beneficial ownership